Ketamine is used and studied in selected pain settings, but route, dose, duration, monitoring, repeated-exposure risks, and quality of evidence vary. An anesthetic approval is not a blanket approval for chronic pain.
Chronic pain
Ketamine is used clinically in some pain settings, while protocols, evidence quality, access, and suitability vary by pain condition.
Medicines appear here because of current research, a specific established clinical context, or sustained public interest. Inclusion does not establish approval, suitability, safety, or effectiveness for an individual.
A condition is a starting point, not the whole story.
Chronic pain includes many mechanisms and diagnoses. Neuropathic pain, centralized pain, inflammatory conditions, and pain complicated by depression or trauma are not interchangeable research questions.
Clarify the pain diagnosis, cardiovascular and urinary health, current opioids or sedatives, substance-use history, mobility and fall risk, the intended functional outcome, and who will manage care after the acute session.
Medicines associated with Chronic pain
Open a field guide for the felt experience, common names, research signal, interactions, contraindications, safety, and legal context unique to each medicine.
C₁₃H₁₆ClNOKetamine
A floaty, dreamlike sense of distance from the body, surroundings, pain, or everyday thought.
Open the full field guide ↗The medicine is one variable.
Diagnosis, intention, medications, physical health, culture, prior experience, consent, setting, support, and follow-up can all change the meaning and risk of a psychedelic experience.